These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18522907)

  • 21. Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders.
    Sharma HS; Muresanu DF; Sharma A
    Expert Rev Neurother; 2013 Oct; 13(10):1085-8. PubMed ID: 24089700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach.
    Tatard VM; Menei P; Benoit JP; Montero-Menei CN
    Curr Drug Targets; 2005 Feb; 6(1):81-96. PubMed ID: 15720216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective.
    Mattson MP; Fu W; Zhang P
    Mech Ageing Dev; 2001 May; 122(7):659-71. PubMed ID: 11322991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-based delivery systems for antiangiogenic therapy.
    Machluf M; Carroll RS
    Biotechnol Genet Eng Rev; 2003; 20():183-95. PubMed ID: 14997852
    [No Abstract]   [Full Text] [Related]  

  • 25. Basic neural transplantation techniques. I. Dissociated cell suspension grafts of embryonic ventral mesencephalon in the adult rat brain.
    Dunnett SB; Björklund A
    Brain Res Brain Res Protoc; 1997 Feb; 1(1):91-9. PubMed ID: 9385053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro generation of three-dimensional substrate-adherent embryonic stem cell-derived neural aggregates for application in animal models of neurological disorders.
    Hargus G; Cui YF; Dihné M; Bernreuther C; Schachner M
    Curr Protoc Stem Cell Biol; 2012 May; Chapter 2():Unit 2D.11. PubMed ID: 22605646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 'current state of play' in transplantation and restoration research of the CNS.
    Eve DJ; Sanberg PR
    Neurotox Res; 2007 Apr; 11(3-4):145-50. PubMed ID: 17449456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomaterials for Enhancing CNS Repair.
    Lim TC; Spector M
    Transl Stroke Res; 2017 Feb; 8(1):57-64. PubMed ID: 27251413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders.
    Kennedy PG
    Brain; 1997 Jul; 120 ( Pt 7)():1245-59. PubMed ID: 9236634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectors.
    Tenenbaum L; Peschanski M; Melas C; Rodesh F; Lehtonen E; Stathopoulos A; Velu T; Brotchi J; Levivier M
    Cell Transplant; 2004; 13(5):565-71. PubMed ID: 15565868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell based-gene delivery approaches for the treatment of spinal cord injury and neurodegenerative disorders.
    Taha MF
    Curr Stem Cell Res Ther; 2010 Mar; 5(1):23-36. PubMed ID: 19951254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of neurogenesis via neurotrophic factors in acupuncture treatments for neurological diseases.
    Shin HK; Lee SW; Choi BT
    Biochem Pharmacol; 2017 Oct; 141():132-142. PubMed ID: 28461125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
    Lundberg C; Björklund T; Carlsson T; Jakobsson J; Hantraye P; Déglon N; Kirik D
    Curr Gene Ther; 2008 Dec; 8(6):461-73. PubMed ID: 19075629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A showcase of bench-to-bedside regenerative medicine at the 2010 ASNTR.
    Eve DJ; Borlongan CV; Sanberg PR
    ScientificWorldJournal; 2011; 11():1842-64. PubMed ID: 22125442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies.
    Giordano C; Albani D; Gloria A; Tunesi M; Batelli S; Russo T; Forloni G; Ambrosio L; Cigada A
    Int J Artif Organs; 2009 Dec; 32(12):836-50. PubMed ID: 20037888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplanted neural progenitor cells survive and differentiate but achieve limited functional recovery in the lesioned adult rat spinal cord.
    Webber DJ; Bradbury EJ; McMahon SB; Minger SL
    Regen Med; 2007 Nov; 2(6):929-45. PubMed ID: 18034631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and Integration of Transplanted Olfactory Ensheathing Cells are Crucial for Spinal Cord Injury Repair: Insights from the Last 10 Years of Animal Model Studies.
    Reshamwala R; Shah M; St John J; Ekberg J
    Cell Transplant; 2019 Dec; 28(1_suppl):132S-159S. PubMed ID: 31726863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Resolution of the Presidium of the Board of the All-Russian Society of Neurologists. Results and prospects of the use of cellular technologies in the treatment of neurological diseases].
    Zh Vopr Neirokhir Im N N Burdenko; 2004; (4):41-2. PubMed ID: 15724553
    [No Abstract]   [Full Text] [Related]  

  • 40. Stem cells for the treatment of neurological disease.
    Rice CM; Halfpenny CA; Scolding NJ
    Transfus Med; 2003 Dec; 13(6):351-61. PubMed ID: 14651741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.